Now that Decan is off the HC books permanently we really need the insight from you and Red.
IYO do you think GBI be a winner with Ascus/Triage and then screening to a lower % down the track?
What sort of screening numbers do you think is realistic considering that you say that ultimatley HPV testing will be used as the primary screen...if GBI can do a genotyped test rather than just a HR test for the same/lower price wouldn't this be attractive?
cheers
GBI Price at posting:
50.0¢ Sentiment: Buy Disclosure: Held